Weight loss medications should be considered as an adjunct to lifestyle modifications in patients with type 2 diabetes who fail to respond to lifestyle interventions after 6 months and who have a BMI ≥ 27kg/m2. Weight loss medication may help patients adhere to dietary recommendation, enabling initial weight loss and preventing weight regain. Pharmacotherapy should be continued in patients who achieve ≥ 5% weight loss after 3-4 months with one weight loss medication. In addition, pharmacotherapy may benefit patients prior and following weight loss surgery to achieve greater total weight loss.
Phentermine is a sympathomimetic anorexigenic agent approved for short-term management of obesity. It is contraindicated in individuals with uncontrolled hypertension, CVD, hyperthyroidism, glaucoma, or recent use of monoamine oxidase inhibitors.
Learn more about type 2 diabetes.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Anne L. Peters. Fast Five Quiz: Type 2 Diabetes and Obesity and Weight Management - Medscape - May 16, 2022.